Clinical Features and Outcomes of Black Patients with Melanoma
This case series identifies patient-level and tumor-level characteristics of melanoma in 48 Black patients at 2 tertiary care centers. (Source: JAMA Dermatology)
Source: JAMA Dermatology - January 24, 2024 Category: Dermatology Source Type: research
Retrospective Case Series of Cocaine-Associated Plasma Cell Orificial Mucositis
This case series establishes the clinicopathological characteristics of plasma cell orificial mucositis. (Source: JAMA Dermatology)
Source: JAMA Dermatology - January 24, 2024 Category: Dermatology Source Type: research
A Patient-Reported Outcome Measure to Assess Disease Control in Chronic Prurigo
This qualitative study develops and validates the Prurigo Control Test, a tool for assessing disease control in chronic prurigo, and identifies a cutoff value for controlled disease to aid treatment decisions. (Source: JAMA Dermatology)
Source: JAMA Dermatology - January 17, 2024 Category: Dermatology Source Type: research
Potential Role of Tranexamine Acid and Nonablative Fractional Resurfacing in Managing Facial Hyperpigmentation —Reply
In Reply We thank Hashemi et al for their engagement and thoughtful reply to our article that highlighted their experience with tranexamic acid (TA) and procedural therapies. We agree that treatment approaches in hyperpigmentation have had great advancements. We also recognize that tranexamic acid offers an additional option for treating melasma, as we discussed in our article. However, more guidance is needed on optimal therapeutic ranges, dosing regimens, length of treatment, and effects on certain patient populations, such as those receiving hormonal treatments and/or with hypercoagulable disorders. While TA has a promi...
Source: JAMA Dermatology - January 17, 2024 Category: Dermatology Source Type: research
Potential Role of Tranexamine Acid and Nonablative Fractional Resurfacing in Managing Facial Hyperpigmentation
To the Editor In reading the recent article by Kundu et al regarding the management of facial hyperpigmentation due to melasma and postinflammatory hyperpigmentation (PIH), we have additional perspectives regarding medical and procedural management given recent advancements described in the literature and our own clinical experience. Regarding medical management, several recent studies have supported the effectiveness and safety of oral tranexamic acid (TA) in treating various pigmentary disorders, such as melasma and PIH. Despite its historical hemostatic indications at higher doses, multiple studies have demonstrated low...
Source: JAMA Dermatology - January 17, 2024 Category: Dermatology Source Type: research
Erythrasma
This case report describes well-demarcated brown plaques with overlying fine scale in the bilateral axillae, inframammary folds, and inguinal folds and widespread coral-red fluorescence. (Source: JAMA Dermatology)
Source: JAMA Dermatology - January 17, 2024 Category: Dermatology Source Type: research
Causes and Clinical Presentation of Drug-Induced Dermatomyositis
This systematic review characterizes causes and clinical presentation of drug-induced dermatomyositis based on the current literature. (Source: JAMA Dermatology)
Source: JAMA Dermatology - January 10, 2024 Category: Dermatology Source Type: research
Factors Affecting Treatment Selection Among Patients With Hidradenitis Suppurativa
This qualitative study examines factors that patients with hidradenitis suppurativa consider when deciding about new treatments. (Source: JAMA Dermatology)
Source: JAMA Dermatology - January 10, 2024 Category: Dermatology Source Type: research
Selumetinib for Caf é-au-Lait Macules and Plexiform Neurofibroma in Pediatric Patients With Neurofibromatosis Type 1
This case report describes 4 patients with a rare autosomal dominant multisystem disorder resulting from NF1 variants that leads to caf é-au-lait macules and neurofibromas. (Source: JAMA Dermatology)
Source: JAMA Dermatology - January 10, 2024 Category: Dermatology Source Type: research
Risk of Alopecia Areata After COVID-19
This cohort study examines the incidence, prevalence, and risk of alopecia areata after COVID-19. (Source: JAMA Dermatology)
Source: JAMA Dermatology - January 10, 2024 Category: Dermatology Source Type: research
Error in Figure 2
In the Consensus Statement titled “International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis,” there was an error in panel B of Figure 2. The black vertical dashed line was meant to mark 30%, not 25%. The article has been corrected online. (Source: JAMA Dermatology)
Source: JAMA Dermatology - January 10, 2024 Category: Dermatology Source Type: research
Segmental Skin Induration in a Boy
An 11-year-old boy presented with progressive unilateral skin hardening on his right thigh and buttock for 7 years. What is your diagnosis? (Source: JAMA Dermatology)
Source: JAMA Dermatology - January 10, 2024 Category: Dermatology Source Type: research
Genetic Risk Factors for Early-Onset Merkel Cell Carcinoma
This case-control study examines genetic risk factors associated with early-onset Merkel cell carcinoma. (Source: JAMA Dermatology)
Source: JAMA Dermatology - January 3, 2024 Category: Dermatology Source Type: research
Lived Experience of Acne and Acne Treatment in Transgender Patients
This mixed-methods study examines the lived experiences of acne and acne treatment in transgender and gender-diverse individuals. (Source: JAMA Dermatology)
Source: JAMA Dermatology - January 3, 2024 Category: Dermatology Source Type: research
Clinical Characteristics of Erythema Nodosum and Associations With Chronicity and Recurrence
This cohort study characterizes the presentation, causes, treatment, and disease course of erythema nodosum, as well as identifies associations with chronicity and recurrence. (Source: JAMA Dermatology)
Source: JAMA Dermatology - January 3, 2024 Category: Dermatology Source Type: research
